Reverse Takeover in Ireland.

Ireland occupies an unusual position in global capital markets: a small home economy wrapped around one of the densest concentrations of US-facing corporate operations anywhere in Europe. Generations of technology and pharmaceutical groups have used Irish holding companies as their transatlantic hinge, so the plc and the Irish-incorporated parent are already fluent currency in American boardrooms and law firms.

For an Irish private company eyeing public capital, that familiarity matters. A reverse takeover into a Nasdaq, NYSE American, or OTC shell lets founders reach US investors through a structure their counterparties already trust, rather than starting from an unfamiliar vehicle.

Ireland at a glance

Home market	Euronext Dublin
Home regulator	Central Bank of Ireland (CBI)
Currency	Euro (EUR)
Notable sectors	Technology, life sciences and pharma, aviation-adjacent, and financial services.
US venues	Nasdaq, NYSE American, and the OTC Markets (OTCQX, OTCQB)
Our role	Advisory and arranger of the reverse takeover; not a broker-dealer, law firm or auditor.

Why Ireland companies list in the United States

Ireland's centre of economic gravity leans west. Many Irish companies sell into the United States, compete with US peers, and are staffed by teams accustomed to US reporting rhythms — so a US listing frequently reflects where the business already lives. American markets offer valuation depth for software and life-sciences stories, dollar capital that matches dollar revenue, and an acquisition currency for consolidating fragmented markets. There is also a well-worn precedent of Irish-domiciled companies trading on US exchanges, which means investors do not treat an Irish parent as exotic. For a founder-led group, a reverse takeover converts that transatlantic orientation into a public profile without the full timetable and syndicate of an underwritten offering.

The Ireland market and a US listing

Euronext Dublin is the domestic venue, overseen in prudential and conduct terms by the Central Bank of Ireland (CBI), but it is a comparatively small equity market and a limited pool for growth-company valuations. Ambitious Irish issuers have historically looked outward, and a US listing generally offers materially deeper liquidity and a specialist investor base for technology and pharma. A reverse takeover's timetable is typically shaped by diligence and disclosure readiness rather than a full local IPO process. Companies weighing both should map how any Euronext Dublin ambitions and Irish company-law obligations interact with a US quote, but for many the practical choice is simply where the natural investor audience sits.

Sectors driving Ireland US listings

Ireland's public-market appeal clusters around software and enterprise technology, pharmaceuticals and med-tech, and aviation-adjacent finance and leasing — sectors where the country hosts globally significant operations and where US investors have deep, established appetite. Financial-services and payments companies also translate well, given the international character of Dublin's sector. Because American analysts already cover Irish-linked names in these categories, a smaller issuer can benchmark itself against recognised comparables, which sharpens the equity narrative and helps an incoming US shareholder base underwrite the story with confidence.

Cross-border structuring from Ireland

Structuring for Irish issuers is usually more straightforward than for emerging markets. An Irish plc or private limited company is well understood by US counsel and auditors, and an Irish-incorporated parent can frequently serve directly as the listed entity, which is one reason Ireland has long been a favoured transatlantic holding location. There are no EU-internal exchange-control barriers. The substantive early work is cross-border tax — Irish trading-company and holding-regime treatment, US anti-inversion rules where a US target or shell is involved, withholding on dividends, and treaty positioning — all of which should be modelled with specialist Irish and US tax and securities advisers before the reverse merger is documented. Treat this as orientation and defer to counsel on the specific facts.

Audit and reporting readiness

Irish companies generally prepare accounts under IFRS as adopted by the EU, or in some cases Irish GAAP, so the route to a US listing involves either an IFRS presentation available to foreign private issuers or a conversion to US GAAP by venue and status. The statements must be audited by a PCAOB-registered firm; given Ireland's large professional-services base, such auditors are readily available. Even so, producing US-standard, audit-ready financials across the required comparative periods is typically the gating item, and beginning the conversion and audit early avoids it becoming the bottleneck.

Choose a US venue

The same Ireland company can target different US venues depending on its size and readiness. Each page below sets out the route and the listing standards.

• Nasdaq listingIreland → Nasdaq
• NYSE American listingIreland → NYSE American
• OTC Markets listingIreland → OTC Markets

Reverse Takeover in Ireland — frequently asked questions

Related markets

• United KingdomLSE · AIM
• GermanyFSE · Xetra
• FranceEuronext
• SwitzerlandSIX

This page is general, educational information about listing routes and is not investment, legal, tax, or accounting advice, nor an offer or solicitation. Regulatory details change and vary by circumstance; obtain advice from qualified US securities counsel and your home-market advisers. See our disclosures.